CVE-2024-13026
Inadequate Encryption Strength Vulnerability in Roche Algo Edge
A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.
Attack profile
How easy it is to exploit
- Attack vector
- Adjacent network
- Complexity
- High
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
CVE List Score used
6.1
Inadequate Encryption Strength Vulnerability in Roche Algo Edge
A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.
- Record
CVE-2024-13026- CVSS 4.0
- 6.1 Medium
CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/S:N/AU:N/R:A/V:D/RE:L/U:Clear - Weakness
- CWE-326
- Updated
- 2026-11-02
EUVDEUVD-2024-51283
6.1
A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.
- Record
EUVD-2024-51283- CVSS 4.0
- 6.1 Medium
CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/S:N/AU:N/R:A/V:D/RE:L/U:Clear - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-mvrq-wf2x-8c9p
6.1
A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify®...
A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.
- Record
GHSA-mvrq-wf2x-8c9p- CVSS 4.0
- 6.1 Medium
CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:N/R:A/V:D/RE:L/U:Clear - Weakness
- CWE-326
- Updated
- 2026-11-02
NVD
6.1
A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.
- Record
CVE-2024-13026- CVSS 4.0
- 6.1 Medium
CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:N/R:A/V:D/RE:L/U:Clear - Weakness
- CWE-326
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2024-13026 is a medium vulnerability (CVSS 6.1) in Roche Diagnostics Algorithm Suite, published January 17, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.13%, the 2nd percentile. No source names a fixed version.